References
  1. Beardsley AL, Nitu ME, Cox EG, et al. An evaluation of various ventilator-associated infection criteria in a PICU. Pediatr Crit Care Med 2016; 17:73-80
  2. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Disease Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63(5):e61-111
  3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health-care associated infection and criteria for specific types of infection in the acute care setting. Am J Infect Control 2008; 36:309-332
  4. Wheeler DS, Whitt JD, Lake M, et al. A case-control study on the impact of ventilator-associated tracheobronchitis in the PICU.Pediatr Crit Care Med 2015; 16(6):565-71
  5. Mhanna MJ, Elsheikh IS, Super DM. Risk factors and outcome of ventilator associated tracheitis (VAT) in pediatric trauma patients.Pediatr Pulmonol 2013; 48(2):176-81
  6. Craven DE, Hudcova J, Rashid J. Antibiotic therapy for ventilator-associated tracheobronchitis: a standard of care to reduce pneumonia, morbidity and costs? Curr Opin Pulm Med 2015; 21(3):250-9
  7. Nseir S, Martin-Loeches I, Makris D, et al. Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia. Crit Care2014; 18(3):R129
  8. Tamma PD, Turnbull AE, Milsone AM, et al. Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis 2011; 52(11):1324-31
  9. Cipro® [package insert]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2016
  10. Levofloxacin [package insert]. Princeton, NJ: Sandoz, Inc.; 2019
  11. Richard DA, Nousia-Arvanitakis S, Sollich V, et al. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Pediatr Infect Dis J 1997; 16(6):572-578
  12. Schaad UB, Wedgwood J, Ruedeberg A, et al. Ciprofloxacin as antipseudomonal treatment in patients with Cystic Fibrosis.Pediatr Infect Dis J 1997; 16:106-111
  13. The Sanford guide to antimicrobial therapy (2019). Dallas, TX: Antimicrobial Therapy, Inc.
  14. Craven DE, Lei Y, Ruthazer R, et al. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med2013; 126(6):542-9
  15. Craven DE, Hudcova J, Craven KA, et al. Antibiotic treatment of ventilator-associated tracheobronchitis: to treat or not to treat?Curr Opin Crit Care 2014; 29(5):532-41
  16. Peña-López Y, Pujol M, Campins M, et al. Implementing a care bundle approach reduces ventilator-associated pneumonia and delays ventilator-associated tracheobronchitis in children: differences according to endotracheal or tracheostomy devices. Int J Infect Dis 2016; 52:43-8
  17. Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care  2005; 9:R238–45
  18. Martin-Loeches I, Povoa P, Rodriguez A, et al. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicenter, prospective, observational study. Lancet Respir Med 2015; 3:859-68
  19. Pontes LG, de Menezes FG, Gonçalves P, et al. Risk factors for mortality in ventilator-associated tracheobronchitis: a case-control study. Einstein 2017; 15(1):61-4
  20. Nseir S, Pompeo CD, Pronnniter P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome.Eur Respir J 2002; 20(6):1483-9
  21. Chastre J, Wolff M, Fagon J, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults.JAMA 2003;290;2588-2598
  22. Nseir S, Favory R, Jozefowicz El, et al. Antimicrobial treatment of ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 2008; 12(03):R62.
  23. Keane S, Vallecoccia MS, Nseir S, et al. How can we distinguish ventilator-associated tracheobronchitis from pneumonia? Clin Chest Med 2018; 39(4):785-96
  24. Rodriguez A, Povoa P, Nseir S, et al. Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey. Crit Care 2014; 18(1):R32
  25. Alves AE, Pereira JM. Antibiotic therapy in ventilator-associated tracheobronchitis: a literature review. Rev Bras Ter Intensiva2018; 30(1):80-5
  26. U.S Centers for Disease Control and Prevention. The National Safety Network (NHSN) 2021 Patient Safety Component Manual.